FERMENTALG (ALGAE.PA)

EUR 0.44

(0.0%)

Total Debt Summary of FERMENTALG

  • FERMENTALG's latest annual total debt in 2023 was 15.35 Million EUR , up 39.35% from previous year.
  • FERMENTALG's latest quarterly total debt in 2024 Q2 was 13.99 Million EUR , down 0.0% from previous quarter.
  • FERMENTALG reported annual total debt of 11.01 Million EUR in 2022, up 14.69% from previous year.
  • FERMENTALG reported annual total debt of 9.6 Million EUR in 2021, down -39.36% from previous year.
  • FERMENTALG reported quarterly total debt of 13.99 Million EUR for 2024 Q1, down -8.84% from previous quarter.
  • FERMENTALG reported quarterly total debt of 15.35 Million EUR for 2023 FY, up 39.35% from previous quarter.

Annual Total Debt Chart of FERMENTALG (2023 - 2019)

Historical Annual Total Debt of FERMENTALG (2023 - 2019)

Year Total Debt Total Debt Growth
2023 15.35 Million EUR 39.35%
2022 11.01 Million EUR 14.69%
2021 9.6 Million EUR -39.36%
2020 15.84 Million EUR 0.0%
2019 - EUR 0.0%

Peer Total Debt Comparison of FERMENTALG

Name Total Debt Total Debt Difference
Nicox S.A. 25.15 Million EUR 38.958%
European Medical Solutions 18.13 Million EUR 15.316%
argenx SE 18.1 Million EUR 15.196%
BioSenic S.A. 28.16 Million EUR 45.478%
Celyad Oncology SA 902 Thousand EUR -1602.217%
Hyloris Pharmaceuticals SA 5.29 Million EUR -190.026%
Onward Medical N.V. 16.87 Million EUR 9.008%
Oxurion NV 12.33 Million EUR -24.485%
PHAXIAM Therapeutics S.A. 10.19 Million EUR -50.544%
Financière de Tubize SA 79.2 Million EUR 80.614%
UCB SA 3.03 Billion EUR 99.495%